A case of malignant insulinoma responsive to somatostatin analogs treatment

被引：0
作者：
Mariasmeralda Caliri
Valentina Verdiani
Edoardo Mannucci
Vittorio Briganti
Luca Landoni
Alessandro Esposito
Giulia Burato
Carlo Maria Rotella
Massimo Mannelli
Alessandro Peri
机构：
[1] University of Florence,Endocrine Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”
[2] Careggi University Hospital,Diabetology Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”
[3] University of Florence,Division of Nuclear Medicine
[4] Careggi University Hospital,General and Pancreatic Surgery Department
[5] Careggi University Hospital,Department of Pathology and Diagnostics
[6] The Pancreas Institute-University of Verona Hospital Trust,undefined
[7] University of Verona Hospital Trust,undefined
来源：
BMC Endocrine Disorders | / 18卷
关键词：
Insulinoma; Hypoglycemia; Somatostatin analogs; Octreotide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A case of malignant insulinoma responsive to somatostatin analogs treatment
    Caliri, Mariasmeralda
    Verdiani, Valentina
    Mannucci, Edoardo
    Briganti, Vittorio
    Landoni, Luca
    Esposito, Alessandro
    Burato, Giulia
    Rotella, Carlo Maria
    Mannelli, Massimo
    Peri, Alessandro
    BMC ENDOCRINE DISORDERS, 2018, 18
  • [2] Preoperative treatment of benign insulinoma: diazoxide or somatostatin analogues?
    Gilliaux, Quentin
    Bertrand, Claude
    Hanon, Francois
    Donckier, Julian E.
    ACTA CHIRURGICA BELGICA, 2022, 122 (02) : 136 - 139
  • [3] Treatment of malignant endocrine pancreatic tumors with a combination of α-interferon and somatostatin analogs
    M.-L. Fjällskog
    A. Sundin
    J.-E. Westlin
    K. Öberg
    E. T. Janson
    B. Eriksson
    Medical Oncology, 2002, 19 : 35 - 42
  • [4] Treatment of malignant endocrine pancreatic tumors with a combination of α-interferon and somatostatin analogs
    Fjällskog, ML
    Sundin, A
    Westlin, JE
    Öberg, K
    Janson, ET
    Eriksson, B
    MEDICAL ONCOLOGY, 2002, 19 (01) : 35 - 42
  • [5] OctreotideFatal hypoglycaemia in a patient with malignant insulinoma: case report
    Reactions Weekly, 2007, 1161 (1) : 19 - 19
  • [6] Pasireotide for the treatment of refractory hypoglycaemia from malignant insulinoma
    Hendren, Nicholas S.
    Panach, Kamaldeep
    Brown, Timothy J.
    Peng, Lan
    Beg, Muhammad S.
    Weissler, Jonathan
    Mirfakhraee, Sasan
    CLINICAL ENDOCRINOLOGY, 2018, 88 (02) : 341 - 343
  • [7] Management of malignant insulinoma
    J. C. Ferrer-García
    V. Iranzo González-Cruz
    S. Navas-DeSolís
    M. Civera-Andrés
    C. Morillas-Ariño
    Á. Merchante-Alfaro
    C. Caballero-Díaz
    C. Sánchez-Juan
    C. Camps Herrero
    Clinical and Translational Oncology, 2013, 15 : 725 - 731
  • [8] Advances in the treatment of gastroenteropancreatic neuroendocrine neoplasms with somatostatin analogs
    Lu, Ming
    Zhang, Panpan
    Zhang, Jianwei
    Li, Jie
    JOURNAL OF PANCREATOLOGY, 2023, 6 (01) : 23 - 27
  • [9] Management of malignant insulinoma
    Ferrer-Garcia, J. C.
    Iranzo Gonzalez-Cruz, V.
    Navas-DeSolis, S.
    Civera-Andres, M.
    Morillas-Arino, C.
    Merchante-Alfaro, A.
    Caballero-Diaz, C.
    Sanchez-Juan, C.
    Camps Herrero, C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (09) : 725 - 731
  • [10] Pasireotide for malignant insulinoma
    Amit Tirosh
    Salomon M. Stemmer
    Evgeny Solomonov
    Eldad Elnekave
    Wolfgang Saeger
    Yelena Ravkin
    Kobi Nir
    Yeela Talmor
    Ilan Shimon
    Hormones, 2016, 15 : 271 - 276
12345